Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Beyond diagnostic accuracy: the clinical utility of diagnostic tests.

Bossuyt PM, Reitsma JB, Linnet K, Moons KG.

Clin Chem. 2012 Dec;58(12):1636-43. Review.

2.

The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed.

Van den Bruel A, Cleemput I, Aertgeerts B, Ramaekers D, Buntinx F.

J Clin Epidemiol. 2007 Nov;60(11):1116-22. Epub 2007 Aug 29. Review.

PMID:
17938052
3.

Assessing the clinical utility of diagnostics used in drug therapy.

Woodcock J.

Clin Pharmacol Ther. 2010 Dec;88(6):765-73. doi: 10.1038/clpt.2010.230. Epub 2010 Oct 27. Review.

PMID:
20981005
4.

Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 5. Diagnostic accuracy studies.

Manchikanti L, Derby R, Wolfer L, Singh V, Datta S, Hirsch JA.

Pain Physician. 2009 May-Jun;12(3):517-40. Review.

6.

Various randomized designs can be used to evaluate medical tests.

Lijmer JG, Bossuyt PM.

J Clin Epidemiol. 2009 Apr;62(4):364-73. doi: 10.1016/j.jclinepi.2008.06.017. Epub 2008 Oct 21.

PMID:
18945590
7.

Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation.

Staub LP, Lord SJ, Simes RJ, Dyer S, Houssami N, Chen RY, Irwig L.

BMC Med Res Methodol. 2012 Feb 14;12:12. doi: 10.1186/1471-2288-12-12.

8.

A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers.

Nelson EA, O'Meara S, Craig D, Iglesias C, Golder S, Dalton J, Claxton K, Bell-Syer SE, Jude E, Dowson C, Gadsby R, O'Hare P, Powell J.

Health Technol Assess. 2006 Apr;10(12):iii-iv, ix-x, 1-221. Review.

9.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology.

J Clin Oncol. 2003 Jun 15;21(12):2397-406. Epub 2003 Apr 11.

PMID:
12692171
10.

Additional patient outcomes and pathways in evaluations of testing.

Bossuyt PM, McCaffery K.

Med Decis Making. 2009 Sep-Oct;29(5):E30-8. doi: 10.1177/0272989X09347013. Epub 2009 Sep 2.

PMID:
19726782
11.

A critical synopsis of the diagnostic and screening radiology outcomes literature.

Blackmore CC, Black WC, Jarvik JG, Langlotz CP.

Acad Radiol. 1999 Jan;6 Suppl 1:S8-18.

PMID:
9891161
12.

Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.

Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K, Stone D.

Health Technol Assess. 2007 Dec;11(49):iii-iv, ix-115.

14.

Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies.

Freeman K, Szczepura A, Osipenko L.

Eur J Obstet Gynecol Reprod Biol. 2009 Feb;142(2):91-8. doi: 10.1016/j.ejogrb.2008.10.010. Epub 2008 Dec 9. Review.

PMID:
19081172
15.

[Roaming through methodology. X. The testing of diagnostic procedures].

Bossuyt PM, Lijmer JG, Mol BW.

Ned Tijdschr Geneeskd. 1998 Oct 24;142(43):2345-7. Review. Dutch.

PMID:
9864513
16.

Quantifying the added value of a diagnostic test or marker.

Moons KG, de Groot JA, Linnet K, Reitsma JB, Bossuyt PM.

Clin Chem. 2012 Oct;58(10):1408-17. Epub 2012 Sep 5. Review.

17.

Randomized clinical trials: the meeting place of medical practice and clinical research.

Hughes EG.

Semin Reprod Med. 2003 Feb;21(1):55-64. Review.

PMID:
12806560
18.

Evaluation of new diagnostic technologies: bronchoalveolar lavage and the diagnosis of ventilator-associated pneumonia.

Cook DJ, Brun-Buisson C, Guyatt GH, Sibbald WJ.

Crit Care Med. 1994 Aug;22(8):1314-22. Review.

PMID:
8045152
19.

Current concepts of tumor markers in bladder cancer.

Droller MJ.

Urol Clin North Am. 2002 Feb;29(1):229-34. Review.

PMID:
12109349
20.

Diagnostic randomized controlled trials: the final frontier.

Rodger M, Ramsay T, Fergusson D.

Trials. 2012 Aug 16;13:137. doi: 10.1186/1745-6215-13-137.

Supplemental Content

Support Center